Characterization of fetal serum 5'-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation

Thromb Res. 1998 Jul 15;91(2):83-9. doi: 10.1016/s0049-3848(98)00073-5.

Abstract

The study was performed to indicate the ADPase activity of 5'-nucleotide phosphodiesterase (PDEase) from human umbilical cord blood serum and demonstrates the effect of this enzyme on ADP-induced platelet aggregation. The PDEase was purified by using p-nitrophenyl-5'-TMP as a substrate. The PDEase had a molecular weight of 128,000 daltons, and activity of 103 nmol/min/mg protein. The PDEase activity was inhibited by 5'-AMP, ADP, ATP. But 2'-AMP, 3'-AMP, 3':5' cAMP, and adenosine had no inhibiting effects. Kinetic analysis indicated that ADP was a competitive inhibitor with a Ki value of 4.05x10(-5) M. The enzyme was markedly inhibited by 1 mM EDTA. The ADPase activity of the PDEase was 7.79 nmol/min/mg protein. The hydrolized products of ADP by the PDE ase were AMP and phosphoric acid. The platelet aggregation by ADP was inhibited by the addition of the PDEase in the platelet-rich plasma.

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Adenosine Monophosphate / pharmacology
  • Apyrase / pharmacology
  • Binding, Competitive
  • Fetal Blood / enzymology*
  • Humans
  • Infant, Newborn
  • Phosphodiesterase Inhibitors / pharmacology
  • Phosphoric Diester Hydrolases / blood*
  • Phosphoric Diester Hydrolases / drug effects
  • Phosphoric Diester Hydrolases / physiology*
  • Platelet Aggregation Inhibitors / blood

Substances

  • Phosphodiesterase Inhibitors
  • Platelet Aggregation Inhibitors
  • Adenosine Monophosphate
  • Adenosine Diphosphate
  • Phosphoric Diester Hydrolases
  • Apyrase